Oxygenta Pharmaceutical Q4 Results

  • BSE: 524636
  • NSE: -
  • ISIN: INE102E01018
  • Sector: Biotechnology & Drugs
BSE
74.81.70 (2.33%)
Volume16.27 K
Updated: Mon 25 Nov, 2024 | 15:29:21
NSE
This stock is not traded on NSE
Today: 73.21
76.68
52-Wk: 26.01
108.64

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Oxygenta Pharmaceutical Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 10.557.85-%8.19-%
    Selling/ General/ Admin Expenses Total 5.250.27-%0.54-%
    Depreciation/ Amortization 0.640.40-%0.85-%
    Total Operating Expense 11.0910.50-%11.06-%
    Operating Income -0.54-2.64-%-2.88-%
    Net Income Before Taxes -2.59-3.25-%-4.09-%
    Net Income 8.02-3.25-%-4.29-%
    Diluted Normalized EPS 2.39-2.05-%-2.99-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts